BSAC is establishing a UK Drug Registry (UKAR) to provide prescribers and organisations the opportunity to capture real world usage of antimicrobial agents and identify where real clinical unmet needs lie. This will provide an invaluable resource for future research studies and also enable the sharing of best practice.

The Officers, Chief Executive, and staff of BSAC are deeply saddened to hear that Sir Paul Cosford, PHE Emeritus Medical Director has died. Sir Paul’s contribution to public health was admirable, considerable and will be greatly missed.

This April, the team from BSAC and JAC are joining a group of fundraisers, including Una Health, Page Medical, as well as a number of other individual fundraisers, to help support our global health initiative, Stop Superbugs.

The British Society for Antimicrobial Chemotherapy (BSAC) welcomes the news that UK Prime Minister Boris Johnson has joined more than 20 international leaders in calling for a settlement that will help the world prepare for future pandemics, and is keen to ensure that, as a ‘slow-motion catastrophe’, antimicrobial resistance (AMR) is now made a top priority on the global health security agenda.

Helping healthcare facilities globally to measure and enhance IPC, data collection / usage and antimicrobial stewardship programmes. Reducing preventable deaths from infections through effective antimicrobial use

BSAC is seeking organisations interested in contributing funds to its grants programme.

We're excited to announce that the E-bug Educators Training course, developed by BSAC & Public Health England, is now available in Welsh. It is a free health education resource that provides fun and accessible learning for students in the classroom and/or at home, on the subject of reducing the spread of infections and antibiotic resistance in the UK.

On 23 March, BSAC’s former president, Professor Dilip Nathwani OBE, will give a lecture honouring Professor Jacques Acar's contribution to science and the fight against antimicrobial resistance.